Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic Malignancies

Clinical trial NCT01034475 · COMPLETED

Trial details

NCT number

NCT01034475

Sponsor

Wake Forest University Health Sciences

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2010-03-01

Primary completion

2013-06-01

Enrollment

26

View on ClinicalTrials.gov